Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Clinical Study Using TrovaGene, Inc.s Precision Cancer Monitoring Platform Published In

October 27, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 27, 2014 /PRNewswire/ –Trovagene, Inc., (NASDAQ:TROV) a developer of cell-free molecular diagnostics, today announced the publication of clinical study results in a peer-reviewed journal, …

The Dow Chemical Company Licenses Simulations Plus Software To Assist With Toxicology And Environmental Research

October 27, 2014 – 5:00 am | Edit Post

LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for discovery and development, announced that The Dow Chemical Company (NYSE: DOW) has licensed both its best-in-class GastroPlus and ADMET Predictor software programs.John DiBella, vice president of marketing and sales for Simulations Plus, said, Dow again demonstrates its foresight…

UBM Canon Release: Local Robotics Teams Compete – A “FIRST” At Next Week’s <b>MD&M Minneapolis</b>- October 29-30th At The Minneapolis Convention Center

October 27, 2014 – 5:00 am | Edit Post

SANTA MONICA, Calif., Oct. 24, 2014 /PRNewswire/ –America’s future engineers will connect with world-renown medtech leaders over friendly robotic competition at theMedical Design and Manufacturing …

International Myeloma Foundation???s Research Division Issues New Guidelines For Early Diagnosis Of Multiple Myeloma

October 27, 2014 – 5:00 am | Edit Post

NORTH HOLLYWOOD, Calif.–(BUSINESS WIRE)–The International Myeloma Foundation (IMF) improving the quality of life of myeloma patients while working toward prevention and a cure today announced that the organizations research division, the International Myeloma Working Group (IMWG), has issued new criteria for diagnosing multiple myeloma. Myeloma is a cancer of cells in the bone marrow that affects…

Ciclofilin Pharmaceuticals Appoints As Senior VP Of Corporate Development

October 27, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 27, 2014 (GLOBE NEWSWIRE) — Ciclofilin Pharmaceuticals Inc. (“Ciclofilin” or the “Company”), a developer of broad spectrum antiviral medications, announced today the appointment of Stephen F. Keane as Senior Vice President of Corporate Development. In this role, Mr. Keane will be responsible…

Celladon Corporation Announces Publication Of Data From Its Stem Cell Factor Gene Therapy Program In Circulation Heart Failure

October 27, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 27, 2014 (GLOBE NEWSWIRE) — Celladon Corporation (Nasdaq:CLDN), a biotechnology industry leader in the field of cardiovascular gene therapy, today announced together with researchers at the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai, the results of pre…

International Myeloma Foundation???s Research Division Issues New Guidelines For Early Diagnosis Of Multiple Myeloma

October 27, 2014 – 5:00 am | Edit Post

NORTH HOLLYWOOD, Calif.–(BUSINESS WIRE)–The International Myeloma Foundation (IMF) improving the quality of life of myeloma patients while working toward prevention and a cure today announced that the organizations research division, the International Myeloma Working Group (IMWG), has issued new criteria for diagnosing multiple myeloma. Myeloma is a cancer of cells in the bone marrow that affects…

Cytori Therapeutics, Inc. To Webcast Third Quarter Financial Results On November 6

October 27, 2014 – 5:00 am | Edit Post

Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its third quarter financial results and business update on Thursday, November 6, 2014 at 5:30 PM Eastern Time. The dial-in information is as follows: Dial-In Number: 1.877.402.3914Conference ID: 26821138 Help employers find you! Check out all the

Arena Pharmaceuticals, Inc. Announces Third Quarter 2014 Conference Call And Webcast On Monday, November 3

October 27, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 27, 2014 /PRNewswire/ — Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announcedthat it will host a conference call and webcast at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time) on Monday, November 3, 2014…

DJO Global Announces Date For Release Of Third Quarter 2014 Results

October 27, 2014 – 5:00 am | Edit Post

DJO Global, Inc., a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced the following information for the release of its third quarter 2014 financial results and a conference call to discuss those results. Help employers find you! Check out all the